peptide-solutions
GHRH analog for metabolic and body composition research
Research Compound
Manufactured under strict quality control protocols with full analytical testing. Certificate of Analysis (COA) available upon request.

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). Research focuses on its ability to stimulate GH secretion and its effects on body composition, particularly visceral adiposity.
Compound Specifications
Select the amount contained in each vial.
Choose one vial, or choose a kit with 10 units priced as 8.
Amount per vial: 1 unit
Scientific Documentation
Detailed research information, pharmacological profile, and handling specifications
Tesamorelin binds to GHRH receptors in the pituitary gland, stimulating the synthesis and pulsatile release of endogenous growth hormone. This downstream GH release leads to IGF-1 production and metabolic effects. In research and experimental models, binding to GHRH receptors on pituitary somatotrophs leads to: • Continuation and elevation of physiological GH pulse • cAMP/PKA signaling increase • Endogenous GH secretion The nature of Tesamorelin causes it to maintain physiological GH secretion, unlike exogenous administration sources.
Verified Buyer Reviews
Loading reviews...
This product is intended strictly for laboratory and research purposes only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm that you are an authorized researcher or institution and that this product will be used solely for legitimate research purposes in compliance with all applicable laws and regulations.
Other research peptides you may be interested in

GLP-1 receptor agonist for metabolic research
from $83

Dual GLP-1/GIP receptor agonist for metabolic research
from $109

Mitochondrial peptide for metabolic research (40 mg per vial)
from $70